Airway Clearance is Considered a Cornerstone of Therapy Aimed at Minimizing the Effects of Lung Diseases Such as Bronchiectasis

Break the vicious cycle of Bronchiectasis with AffloVest HFCWO Airway Clearance Therapy

Importance of Airway Clearance Therapy

Airway clearance therapies can help manage the symptoms of chronic respiratory diseases.  By providing airway clearance therapies, studies show a reduction in hospitalizations, exacerbations and healthcare costs.1 Airway clearance therapy is designed for individuals whose cough mechanics are altered and whose ability to mobilize and clear airway secretions is compromised.  For decades, airway clearance therapy has been considered one of the cornerstones of therapy for the prevention and treatment of pulmonary diseases and respiratory dysfunction to aid in the removal of the mucus that cause airway obstruction. Early diagnosis and implementation of airway clearance therapy (ACT), coupled with management of infections and airways inflammation, can help break the vicious cycle associated with chronic pulmonary and neuromuscular respiratory diseases.2

Personalizing Airway Clearance Therapy

When choosing an airway clearance therapy, it is important to take into consideration the patient’s  preferences. Personalizing airway clearance is important as it needs to address specific patient needs.3 An individualized strategy should consider the patient’s disease state, preference and motivation. An airway clearance regimen should be effective, efficient, and easy to use independently or with minimal assistance. It should also be flexible, comfortable and adaptable to meet the changing needs of the individual patient.

Adherence to airway clearance therapy can significantly influence outcomes of the therapy, therefore it is important to select a therapy that the patient will comply to regularly. Several studies have suggested that poor adherence to prescribed ACT exists across all age ranges. Lack of adherence has been linked to lengthy treatment times, perceived lack of efficacy, coping mechanisms, level of knowledge of the therapy, and personal preference for the ACT device or therapy.4

Airway Clearance Options

One of the most effective airway clearance therapies is a high frequency chest wall oscillation (HFCWO) vest, also referred to as vest therapy.  Several studies report that HFCWO mobilizes more secretions than manual CPT, aids in mucus expectoration (coughing up of mucus),  and contributes to stabilization or improvement of lung function.5

AffloVest is the first battery-operated HFCWO therapy that lets patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases receive state-of-the-art airway clearance therapy (ACT) on the go. With over 10,000 already in clinical use, AffloVest is a proven ACT. The AffloVest is designed to provide patients the freedom and mobility during use to streamline therapy, enhance airway clearance, help mobilize lung secretions, and promote treatment adherence.

The AffloVest provides patient-specific therapy with eight anatomically targeted oscillating motors to create eight individual pressure waves that target all the lobes of the lungs, front and back, and is designed to mimic the gold standard of Chest Physical Therapy, in order to help effectively mobilize secretions. With seven size variations and adjustable shoulder and chest straps, the ergonomic fit of the AffloVest can accommodate different patients’ needs for anatomically targeted therapy that fits young children and adults.

Request More Information About AffloVest

  1. Weycker, D., et al., Prevalence and Economic Burden of Bronchiectasis. Clinical Pulmonary Medicine 2005;12:205.
  2. Volsko, T. Airway Clearance Therapy: Finding the Evidence. Respiratory Care 2013 Vol 58 No 10 p. 1669-1678.
  3. McIlwaine, M., et al. Personalizing airway clearance in chronic lung disease. European Respiratory Review 2017; 26: 160086.
  4. McCullough, et al., Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulmonary Medicine, 2014; 14 p. 107.
  5. Nicolini, A. et al., Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis. BMC Pulmonary Medicine. 2013;13:21.